Although some details are still murky, a first-blush analysis of Obama Administration’s fiscal year 2011 budget doesn’t look good for US efforts to combat the HIV and tuberculosis epidemics. From treatment to prevention, these global health threats could get short-changed under the White House plan. Let’s start with PEPFAR, the President’s Emergency Plan for AIDS Relief. […]
New results from a tuberculosis vaccine trial indicate that the Mycobacterium vaccae (MV) was effective in preventing TB among people with HIV. Given that TB is the No. 1 killer of people with HIV in the developing world, this could be a major advance in the battle against these synergistic scourges. In the seven-year study […]
HIV
With a matter-of-fact and unanimous approval of the PEPFAR Extension Act of 2018, a five-year renewal of the U.S. flagship program to combat HIV globally, the […]
Tuberculosis
THE HAGUE, Netherlands – New results from the ongoing Nix-TB trial continue to confirm a short-course treatment regimen of bedaquiline – one of the two newest […]
Research & Development
A trial to test the safety of, and immune response prompted by, the latest candidate for a vaccine to protect against Zika virus infection has begun […]
Policy
A look at how measles comes into the United States highlights needs for both more vigilant vaccination efforts, and support for global efforts to eliminate the […]